Homestead Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-683,660
| Closed | -$19.7M | – | 137 |
|
|
2023
Q4 | $19.7M | Sell |
683,660
-831,100
| -55% | -$25.1M | 0.5% | 49 |
|
|
2023
Q3 | $50.2M | Buy |
1,514,760
+23,100
| +2% | +$817K | 1.4% | 34 |
|
|
2023
Q2 | $54.7M | Buy |
1,491,660
+6,100
| +0.4% | +$237K | 1.45% | 33 |
|
|
2023
Q1 | $60.6M | Sell |
1,485,560
-28,300
| -2% | -$1.22M | 1.69% | 29 |
|
|
2022
Q4 | $77.6M | Buy |
1,513,860
+2,000
| +0.1% | +$95.9K | 2.07% | 20 |
|
|
2022
Q3 | $66.2M | Sell |
1,511,860
-3,000
| -0.2% | -$146K | 2% | 19 |
|
|
2022
Q2 | $79.4M | Hold |
1,514,860
| – | – | 2.25% | 17 |
|
|
2022
Q1 | $78.4M | Sell |
1,514,860
-676,200
| -31% | -$35.1M | 1.92% | 21 |
|
|
2021
Q4 | $129M | Sell |
2,191,060
-15,700
| -0.7% | -$778K | 2.98% | 8 |
|
|
2021
Q3 | $94.9M | Buy |
2,206,760
+9,400
| +0.4% | +$416K | 2.31% | 13 |
|
|
2021
Q2 | $86M | Sell |
2,197,360
-29,100
| -1% | -$1.13M | 1.99% | 14 |
|
|
2021
Q1 | $80.7M | Sell |
2,226,460
-201,400
| -8% | -$7.15M | 1.93% | 14 |
|
|
2020
Q4 | $89.4M | Sell |
2,427,860
-193,607
| -7% | -$7.1M | 2.21% | 12 |
|
|
2020
Q3 | $91.3M | Sell |
2,621,467
-716,087
| -21% | -$25.1M | 2.5% | 11 |
|
|
2020
Q2 | $104M | Buy |
3,337,554
+3,056
| +0.1% | +$104K | 2.66% | 10 |
|
|
2020
Q1 | $103M | Sell |
3,334,498
-122,034
| -4% | -$4.16M | 3.04% | 9 |
|
|
2019
Q4 | $128M | Sell |
3,456,532
-33,752
| -1% | -$1.2M | 2.68% | 11 |
|
|
2019
Q3 | $119M | Sell |
3,490,284
-119,666
| -3% | -$4.35M | 2.4% | 11 |
|
|
2019
Q2 | $148M | Hold |
3,609,950
| – | – | 2.81% | 12 |
|
|
2019
Q1 | $145M | Sell |
3,609,950
-621,860
| -15% | -$24.9M | 2.72% | 15 |
|
|
2018
Q4 | $175M | Sell |
4,231,810
-105,400
| -2% | -$4.38M | 3.4% | 6 |
|
|
2018
Q3 | $181M | Hold |
4,337,210
| – | – | 2.78% | 10 |
|
|
2018
Q2 | $149M | Hold |
4,337,210
| – | – | 2.35% | 14 |
|
|
2018
Q1 | $146M | Hold |
4,337,210
| – | – | 2.19% | 16 |
|
|
2017
Q4 | $149M | Hold |
4,337,210
| – | – | 2.13% | 17 |
|
|
2017
Q3 | $147M | Hold |
4,337,210
| – | – | 2.24% | 13 |
|
|
2017
Q2 | $138M | Hold |
4,337,210
| – | – | 2.16% | 12 |
|
|
2017
Q1 | $141M | Hold |
4,337,210
| – | – | 2.25% | 11 |
|
|
2016
Q4 | $134M | Hold |
4,337,210
| – | – | 2.1% | 12 |
|
|
2016
Q3 | $139M | Hold |
4,337,210
| – | – | 2.31% | 9 |
|
|
2016
Q2 | $145M | Hold |
4,337,210
| – | – | 2.49% | 8 |
|
|
2016
Q1 | $122M | Buy |
+4,337,210
| New | +$124M | 2.18% | 11 |
|
Other funds holding PFE
Homestead Advisers's PFE Position: Q1 2024 in Review
Homestead Advisers sold out of Pfizer (PFE) in Q1 2024, closing a stake of 683,660 shares — an estimated $19.7M sold.
Homestead Advisers first reported a position in PFE in Q1 2016 and held it in 32 quarters. The position peaked at $181M in Q3 2018. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Homestead Advisers reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Homestead Advisers sold 683,660 Pfizer shares in Q1 2024, an estimated $19.7M.
- Homestead Advisers first reported a position in Pfizer in Q1 2016 and held it in 32 quarters.
- Homestead Advisers's Pfizer position peaked at $181M in Q3 2018.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Homestead Advisers's 13F filing for Q1 2024, filed 10 May 2024.